As shown in Figures 11A–C, ZFPM2 expression did not differ between the two groups (p = 0.3646), whereas LGALS1 and TMEM56 expression levels were significantly decreased in AML samples than that of the normal samples (all p < 0.05). Here, ZFPM2 is linked to acute myeloid leukemia.